Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-28 Sale | 2021-12-30 5:20 pm | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 539,283 | $2.4502 | $1,321,329 | 551,862 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-09 Option Award | 2023-03-10 7:06 pm | N/A 2033-03-09 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 5,310 | $1.35 | 46,771 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 13,020 | $0 | 46,771 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 8:43 pm | N/A 2032-03-10 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 450,000 | $0 | 450,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 7:42 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 52,081 | $0 | 52,081 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 510,838 | $0 | 551,862 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 79,689 | $1.14 | 551,862 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 194,250 | $0.6919 | 551,862 (Direct) | View |
| 2021-12-28 Exercise | 2021-12-30 5:20 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 236,899 | $2.11 | 551,862 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 5:00 pm | N/A 2031-03-15 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 419,500 | $0 | 419,500 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 5:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 444,000 | $0 | 444,000 (Direct) | View |